Taysha Gene Therapies, Inc. (NASDAQ:TSHA) showed up in the 13F filings of 190 institutional investors as of December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| Avoro Capital Advisors LLC | 31 Dec, 2025 | 43,400,000 | 21,700,000 | 100.00% | $238,700,000.00 |
| Goldman Sachs Group Inc | 31 Dec, 2025 | 27,385,478 | 14,001,770 | 104.62% | $150,620,130.00 |
| RA CAPITAL MANAGEMENT, L.P. | 31 Dec, 2025 | 23,555,648 | 0 | 0.00% | $105,293,747.00 |
| RA CAPITAL MANAGEMENT, L.P. | 31 Dec, 2025 | 23,555,648 | 0 | 0.00% | $129,556,064.00 |
| Goldman Sachs Group Inc | 31 Dec, 2025 | 22,369,645 | -5,015,833 | -18.32% | $99,992,313.00 |
| Avoro Capital Advisors LLC | 31 Dec, 2025 | 21,700,000 | -21,700,000 | -50.00% | $96,999,000.00 |
| BlackRock, Inc. | 31 Dec, 2025 | 18,643,129 | 2,278,268 | 13.92% | $102,537,212.00 |
| BlackRock, Inc. | 31 Dec, 2025 | 18,365,608 | -277,521 | -1.49% | $82,094,268.00 |
| Morgan Stanley | 31 Dec, 2025 | 18,078,518 | -1,229,085 | -6.37% | $99,431,850.00 |
| Vestal Point Capital, LP | 31 Dec, 2025 | 18,000,000 | 4,250,000 | 30.91% | $80,460,000.00 |
| Morgan Stanley | 31 Dec, 2025 | 17,965,371 | -113,147 | -0.63% | $80,305,209.00 |
| RTW INVESTMENTS, LP | 31 Dec, 2025 | 16,398,297 | -7,955,994 | -32.67% | $90,190,634.00 |
| FMR LLC | 31 Dec, 2025 | 14,321,255 | 792,889 | 5.86% | $64,016,010.00 |
| Vestal Point Capital, LP | 31 Dec, 2025 | 13,750,000 | 8,250,000 | 150.00% | $75,625,000.00 |
| RTW INVESTMENTS, LP | 31 Dec, 2025 | 13,680,248 | -2,718,049 | -16.58% | $61,150,709.00 |
| FMR LLC | 31 Dec, 2025 | 13,528,366 | -1,065,046 | -7.30% | $74,406,012.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 13,267,805 | 418,192 | 3.25% | $72,972,929.00 |
| State Street Corp | 31 Dec, 2025 | 11,209,078 | 418,994 | 3.88% | $50,104,579.00 |
| State Street Corp | 31 Dec, 2025 | 10,790,084 | 3,553,619 | 49.11% | $59,345,462.00 |
| VANGUARD CAPITAL MANAGEMENT LLC | 31 Dec, 2025 | 10,231,502 | 10,231,502 | 0.00% | $45,734,814.00 |